Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer.

Authors:
Heylen E; Verstraete P; Van Aerschot L; Geeraerts SL; Venken T and 11 more

Journal:
Br J Cancer

Publication Year: 2023

DOI:
10.1038/s41416-023-02216-y

PMCID:
PMC10147615

PMID:
36932191

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Br J Cancer

Abbreviation: Br J Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of…
Young Han C; Bedia JS; Yang WL and 19 more (2024) - Transparency Score: 3/6
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and…
Su X; Jin K; Guo Q and 9 more (2024) - Transparency Score: 3/6
Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance…
Mah CY; Nguyen ADT; Niijima T and 12 more (2024) - Transparency Score: 4/6
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relaps…
Hogarty MD; Ziegler DS; Franson A and 15 more (2024) - Transparency Score: 3/6
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling i…
Mezquita L; Oulhen M; Aberlenc A and 9 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This research was funded by Stichting tegen kanker (project F/2020/1333), Fonds Wetenschappelijk Onderzoek (FWO) (G0A4220N), KU Leuven (C14/18/104) and Kom op tegen Kanker (Stand up to Cancer), the Flemish cancer society (project ID: 13035). EH received an FWO PhD fellowship fundamental research (1106121 N). SLG received an SB PhD fellowship from FWO (1S14517N). PV is supported by an FWO PhD fellowship fundamental research (1116822N). KRK was funded by a research grant from FWO (FWO KAN2018 1501419 N), the young investigator grant from KWF (project ID:13486), and the FEBS excellence award 2021."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025